Bone marrow cell cotransplantation with islets improves their vascularization and function

Transplantation

Volumn 89, Issue 6, 2010, Pages 686-693

  Sakata, Naoaki ^a,b   Chan, Nathaniel K ^a   Chrisler, John ^a   Obenaus, Andre ^a   Hathout, Eba ^a  

^a LOMA LINDA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Angiogenesis; Bone Marrow; Endothelial precursor cells; Islet Transplantation

Indexed keywords

INSULIN; TRANSCRIPTION FACTOR PDX 1; VASCULOTROPIN; VON WILLEBRAND FACTOR;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW TRANSPLANTATION; CELL DIFFERENTIATION; CELL FUNCTION; CELL REGENERATION; CONTROLLED STUDY; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; INSULIN BLOOD LEVEL; KIDNEY CAPSULE; MALE; MOUSE; NONHUMAN; PANCREAS ISLET TRANSPLANTATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; STREPTOZOCIN DIABETES;

ANGIOGENIC PROTEINS; ANIMALS; ANTIGENS, CD34; BLOOD GLUCOSE; BONE MARROW CELLS; BONE MARROW TRANSPLANTATION; DIABETES MELLITUS, EXPERIMENTAL; GLUCOSE TOLERANCE TEST; HOMEODOMAIN PROTEINS; INSULIN; ISLETS OF LANGERHANS; ISLETS OF LANGERHANS TRANSPLANTATION; MALE; MICE; MICE, INBRED BALB C; NEOVASCULARIZATION, PHYSIOLOGIC; TIME FACTORS; TRANS-ACTIVATORS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VON WILLEBRAND FACTOR;

EID: 77949881370     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e3181cb3e8d     Document Type: Article

References (35)

1. Ryan EA, Paty BW, Senior PA, et al. Five-year follow-up after clinical islet transplantation. Diabetes 2005; 54: 2060.
2. Shapiro AM, Nanji SA, Lakey JR. Clinical islet transplant: Current and future directions towards tolerance. Immunol Rev 2003; 196: 219.
3. Shapiro AM, Lakey JR, Ryan EA, et al. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free im-munosuppressive regimen. N Engl J Med 2000; 343: 230.
4. Stagner JI, Mokshagundam S, Samols E. Hormone secretion from transplanted islets is dependent upon changes in islet revascularization and islet architecture. Transplant Proc 1995; 27: 3251.
5. Emamaullee JA, Rajotte RV, Liston P, et al. XIAP overexpression in human islets prevents early posttransplant apoptosis and reduces the islet mass needed to treat diabetes. Diabetes 2005; 54: 2541.
6. Menger MD, Yamauchi J, Vollmar B. Revascularization and microcir-culation of freely grafted islets of Langerhans. World J Surg 2001; 25: 509.
7. Biarnes M, Montolio M, Nacher V, Raurell M, et al. Beta-cell death and mass in syngeneically transplanted islets exposed to short-and long-term hyperglycemia. Diabetes 2002; 51: 66.
8. Brunt KR, Hall SR, Ward CA, et al. Endothelial progenitor cell and mesenchymal stem cell isolation, characterization, viral transduction. Methods Mol Med 2007; 139: 197.
9. Satija NK, Singh VK, Verma YK, et al. Mesenchymal stem cell-based therapy: A new paradigm in regenerative medicine. J Cell Mol Med (in press).
10. Hasegawa Y, Ogihara T, Yamada T, et al. Bone marrow (BM) transplantation promotes beta-cell regeneration after acute injury through BM cell mobilization. Endocrinology 2007; 148: 2006.
11. Choi JB, Uchino H, Azuma K, et al. Little evidence of transdifferentia-tion of bone marrow-derived cells into pancreatic beta cells. Diabeto-logia 2003; 46: 1366.
12. Lechner A, Yang YG, Blacken RA, et al. No evidence for significant transdifferentiation of bone marrow into pancreatic beta-cells in vivo. Diabetes 2004; 53: 616.
13. Roitbak T, Li L, Cunningham LA. Neural stem/progenitor cells promote endothelial cell morphogenesis and protect endothelial cells against ischemia via HIF-1alpha-regulated VEGF signaling. J Cereb Blood Flow Metab 2008; 28: 1530.
14. Sepulveda P, Martinez-Leon J, Garcia-Verdugo JM. Neoangiogenesis with endothelial precursors for the treatment of ischemia. Transplant Proc 2007; 39: 2089.
15. Milovanova TN, Bhopale VM, Sorokina EM, et al. Hyperbaric oxygen stimulates vasculogenic stem cell growth and differentiation in vivo. J Appl Physiol 2009; 106: 711.
16. Dai Y, Xu M, WangY, et al. HIF-1alpha induced-VEGF overexpression in bone marrow stem cells protects cardiomyocytes against ischemia. J Mol Cell Cardiol 2007; 42: 1036.
17. Jiang M, Wang B, Wang C, et al. Angiogenesis by transplantation of HIF-1 alpha modified EPCs into ischemic limbs. J Cell Biochem 2008; 103: 321.
18. Jiang M, Wang B, Wang C, et al. Inhibition of hypoxia-inducible factor-1alpha and endothelial progenitor cell differentiation by adenoviral transfer of small interfering RNA in vitro. J Vasc Res 2006; 43: 511.
19. Gotoh M, Maki T, Kiyoizumi T, et al. An improved method for isolation of mouse pancreatic islets. Transplantation 1985; 40: 437.
20. Sakata N, Hayes P, Tan A, et al. MRI assessment of ischemic liver after intraportal islet transplantation. Transplantation 2009; 87: 825.
21. Sakata N, Tan A, Chan N, et al. Efficacy comparison between intrapor-tal and subcapsular islet transplants in a murine diabetic model. Transplant Proc 2009; 41: 346.
22. Soleimani M, Nadri S. A protocol for isolation and culture of mesen-chymal stem cells from mouse bone marrow. Nat Protoc 2009; 4: 102.
23. Miao G, Ostrowski RP, Mace J, et al. Dynamic production of hypoxia-inducible factor-1alpha in early transplanted islets. Am J Transplant 2006; 6: 2636.
24. Di Santo S, Yang Z, Wyler von Ballmoos M, et al. Novel cell-free strategy for therapeutic angiogenesis: In vitro generated conditioned medium can replace progenitor cell transplantation. PLoS ONE 2009; 4: e5643.
25. Li Z, Guo J, ChangQ, et al. Paracrine role for mesenchymal stem cells in acute myocardial infarction. Biol Pharm Bull 2009; 32: 1343.
26. Chung DJ, Choi CB, Lee SH, et al. Intraarterially delivered human umbilical cord blood-derived mesenchymal stem cells in canine cerebral ischemia. J Neurosci Res 2009; 87: 3554.
27. Liu N, Chen R, Du H, et al. Expression of IL-10 and TNF-alpha in rats with cerebral infarction after transplantation with mesenchymal stem cells. Cell Mol Immunol 2009; 6: 207.
28. Laurila JP, Laatikainen L, Castellone MD, et al. Human embryonic stem cell-derived mesenchymal stromal cell transplantation in a rat hind limb injury model. Cytotherapy 2009; 11: 726.
29. Kawamoto A, Katayama M, Handa N, et al. Intramuscular transplantation of granulocyte colony stimulating factor-mobilized CD34-positive cells in patients with critical limb ischemia: A phase I/IIa, multi-center, single-blind and dose-escalation clinical trial. Stem Cells 2009; 27: 2857.
30. Sakata N, Obenaus A, Chan NK, et al. Factors affecting islet graft em-bolization in the liver of diabetic mice. Islets 2009; 1: 26.
31. Akashi T, Shigematsu H, Hamamoto Y, et al. Bone marrow or foetal liver cells fail to induce islet regeneration in diabetic Akita mice. Diabetes Metab Res Rev 2008; 24: 585.
32. Chan J, Clements W, Field J, et al. Transplantation of bone marrow genetically engineeredto express proinsulin II protects against autoimmune insulitis in NOD mice. J Gene Med 2006; 8: 1281.
33. Ikebukuro K, AdachiY, SuzukiY, et al. Synergistic effects ofinjection of bone marrow cells into both portal vein and bone marrow on tolerance induction in transplantation of allogeneic pancreatic islets. Bone Marrow Transplant 2006; 38: 657.
34. Miller R, Cirulli V, Diaferia GR, et al. Switching-on survival and repair response programs in islet transplants by bone marrow-derived vascu-logenic cells. Diabetes 2008; 57: 2402.
35. Nakayama S, Uchida T, Choi JB, et al. Impact of whole body irradiation and vascular endothelial growth factor-A on increased beta cell mass after bone marrow transplantation in a mouse model of diabetes induced by streptozotocin. Diabetologia 2009; 52: 115.